Pulmonx Corporation (NASDAQ:LUNG) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to Pulmonx Second Quarter 2025 Financial Results Conference Call.
Pulmonx Corp (LUNG)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deerfield Management James E. Flynn | 1,890,000 | $4,895,100 | 0.09% | |
| 2. | Millennium Management Israel Englander | 1,166,527 | $3,021,305 | +460% | 0% |
| 3. | Braidwell LP Alex Karnal | 752,541 | $1,949,081 | 0.07% | |
| 4. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 651,100 | $1,686,349 | +30% | 0.11% |
| 5. | Parkman Healthcare Partners Greg Martinez | 605,029 | $1,567,025 | -2% | 0.18% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.06 | 23,321 | $71,362.26 | 117,231 | 2025-06-05 | Filing | |
| $6.84 | 14,245 | $97,435.80 | 219,531 | 2024-08-20 | Filing | |
| $5.51 | 1,700 | $9,367.00 | 11,910 | 2022-11-29 | Filing | |
| $5.29 | 100 | $529.00 | 30,035 | 2022-11-08 | Filing | |
| $5.31 | 5,338 | $28,344.78 | 29,935 | 2022-11-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.16 | 8,000 | $25,280.00 | 87,024 | 2025-06-12 | Filing | |
| $3.13 | 4,661 | $14,588.93 | 366,115 | 2025-06-02 | Filing | |
| $3.13 | 5,262 | $16,470.06 | 370,776 | 2025-06-02 | Filing | |
| $3.13 | 3,721 | $11,646.73 | 213,925 | 2025-06-02 | Filing | |
| $3.13 | 4,340 | $13,584.20 | 217,646 | 2025-06-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,164,681 | $13,376,524 | 0.01% | |
| 2. | 4,261,368 | $11,036,943 | 0% | |
| 3. | 2,690,798 | $6,969,167 | 0% | |
| 4. | 2,293,988 | $5,941,429 | 0% | |
| 5. | 1,125,861 | $2,915,980 | 0% |
News See All
Pulmonx Corporation (NASDAQ:LUNG) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to Pulmonx First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Pulmonx Corporation (NASDAQ:LUNG) Q4 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to Pulmonx Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Pulmonx Corporation (NASDAQ:LUNG) Q3 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Pulmonx Third Quarter 2024 Earnings Conference Call.
Pulmonx Corporation (NASDAQ:LUNG) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Pulmonx Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript
Pulmonx Corporation beats earnings expectations. Reported EPS is $-0.36, expectations were $-0.43.
Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript
Pulmonx Corporation beats earnings expectations. Reported EPS is $-0.36, expectations were $-0.39.
Pulmonx Corporation (NASDAQ:LUNG) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. Welcome to the Pulmonx Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Pulmonx Corporation (NASDAQ:LUNG) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by. Welcome to the Pulmonx Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Pulmonx Corporation (NASDAQ:LUNG) Q1 2023 Earnings Call Transcript
Operator: Thank you for standing by. Welcome to the Pulmonx First Quarter 2023 Earnings Conference Call. As a reminder, today’s conference is being recorded.
Billionaire Hedge Funds
